Why Pfizer Might Want Ranbaxy
The Indian pharma's right to sell a generic version of Lipitor in two years may make it a necessary buy. 5 months ago
Forbes Click here to Read the Full StoryThe Indian pharma's right to sell a generic version of Lipitor in two years may make it a necessary buy. 5 months ago
Forbes Click here to Read the Full Story